| 12:45-13:00 | Opening Ceremony | ||
| 13:00-14:30 | I. Session: Immune System and Central Nervous System Interaction Session Chairs: Günnur Deniz, Güneş Esendağlı |
||
| 13:00-13:30 | Natural Immunity Jülide Duymaz Tozkır |
||
| 13:30-14:00 | Adaptive Immunity Güneş Esendağlı |
||
| 14:00-14:30 | Tolerance and Autoimmunity Umut Can Küçüksezer |
||
| 14:30-14:40 | Coffee Break  |
||
| 14:40-16:10 | II. Session: Neuroinflammation and Neurodegeneration Session Chairs: Aslı Tuncer, Atay Vural |
||
| 14:40-15:10 | Routes of Immune Cell Entry into the Central Nervous System: Barriers and Glymphatic System Tuncay Gündüz |
||
| 15:10-15:40 | Glial Cells in Neurodegeneration: Friends or Foes? Şermin Genç |
||
| 15:40-16:10 | Inflammatory Mechanisms in Neurodegeneration |
||
| 16:10-16:30 | Coffee Break |
||
| 16:30-17:15 | Quality of Life in MS - With the contributions of Genveon Session Chair: Hüsnü Efendi |
||
|
Quality of Life in Multiple Sclerosis, Lifestyle Changes Ayşe Nur Yüceyar |
|||
| Turkish Yoga Study on Multiple Sclerosis Patients Ahmet Özşimşek |
|||
| 17:15-18:00 | Oral Presentations Session Chairs: Murat Kürtüncü, Barbaros Oral |
||
| Speakers:
Zeynep Kaya, Ceyda Nur Altınışık, Merve Çebi |
|||
| 18:00-18:20 | Coffee Break |
||
| 18:20-19:00 | Challenging Cases Session Chairs: Levent Sinan Bir, Münire Kılıç, Belgin Petek Balcı |
||
| Sedat Şen Serkan Emekli |
|||
| 19:00-19:30 | National and International Project Opportunities Session Chairs: Vuslat Yılmaz, Yasemin Gürsoy Özdemir |
||
| Nafize Selcan Türker | |||
| 19:30-21:00 | Dinner  |
||
| 08.00- 09.00 | Oral Sessions Poster Sessions |
||
| Hall I: Semra Mungan, Meral Seferoğlu |
|||
| Hall II: Gençer Genç, Yusuf Tamam |
|||
| Hall III: Hatice Mavioğlu, Mehmet Ufuk Aluçlu |
|||
| Hall IV: Güher Saruhan Direskeneli, Tuncay Gündüz |
|||
| Posters: Alev Leventoğlu, Yılmaz İnanç |
|||
| 09:00-10:30 | III. Session: New Mechanisms of Autoimmunity Session Chairs: Münife Neyal, Güher Saruhan Direskeneli |
||
| 09:00-09:30 | Mechanisms of Demyelination and Astrogliopathy Edgar Meinl |
||
| 09:30-10:00 | The Role of Complement in Autoimmunity Erdem Tüzün |
||
| 10:00-10:30 | IgG4-Related Autoimmunity Mechanisms Adam Handel |
||
| 10:30- 11:00 | Coffee Break |
||
| 11:00-12:00 | IV. Session: New Perspectives in the Immunopathogenesis of Multiple Sclerosis Session Chairs: Rana Karabudak, Ayşe Altıntaş |
||
| 11:00-11:30 | Meningeal Inflammation in Multiple Sclerosis Richard Reynolds |
||
| 11:30-12:00 | EBV and Autoimmunity Barbara Serafini |
||
| 12:00-13:30 | Lunch Break |
||
| 13:30-14:15 | Long-Term Treatment Management and Clinical Reflections of Cladribine - With the contributions of Merck Session Chair: Aksel Siva |
||
| Long-Term Treatment Management and Clinical Reflections of Cladribine Refik Pul |
|||
| 14:15- 14:30 | Coffee Break |
||
| 14:30-16:00 | V. Session: Challenges in the Diagnosis and Monitoring of Multiple Sclerosis Session Chairs: Canan Yücesan, Burcu Altunrende |
||
| 14:30-15:00 | 2017 MS Diagnosis Criteria: Unmet Needs Aksel Siva |
||
| 15:00-15:30 | Rare Diseases in the Differential Diagnosis of Multiple Sclerosis Murat Kürtüncü |
||
| 15:30-16:00 | Special Situations (Pregnancy, Lactation, Military Service, Epilepsy) Cihat Uzunköprü |
||
| 16:00-16:10 | Coffee Break |
||
| 16:10-16:40 | Oral Presentations Session Chair: Erdem Tüzün, Haluk Gümüş |
||
| Speakers: Özlem Ethemoğlu, Abdulkadir Tunç |
|||
| 16:40-17:25 | Current Situation of Neuromyelitis Optica Spectrum Disorder - With the contributions of Alexion | ||
| 16:40-16:50 | Epidemiology of Neuromyelitis Optica Spectrum
Disorder in Türkiye Murat Kürtüncü |
||
| 16:50-17:15 | Recent Developments in the Treatment of Neuromyelitis
Optica Spectrum Disorder and Eculizumab Treatment Francesco Sacca |
||
| 17:15-17:25 | Q & A | ||
| 17:25-17:45 | Coffee Break |
||
| 17:45-18:40 | Challenging Cases Session Chairs: Taşkın Duman, Esra Gürsoy, Erkingül Birday |
||
| İlknur Aydın Cantürk Gökçen Gözübatık Çelik Ahmet Kasım Kılıç |
|||
| 19:00 | Dinner |
||
| 20:00-22:30 | Karaoke Night Jury: Gülşen Akman, Nur Yüceyar, Serkan Özakbaş, Serhan Sevim, Rana Karabudak, Recai Türkoğlu |
||
| 08.00- 09.00 | Oral Sessions Poster Sessions |
||
| Hall I: Serpil Bulut, İlksen Çolpak Işıkay |
|||
| Hall II: Muhteşem Gedizlioğlu, Figen Tokuçoğlu |
|||
| Hall III: Hayat Güven, Aslı Tuncer |
|||
| Poster: Dilcan Kotan, Nalan Güneş |
|||
| 09:00-10:30 | III. Session: Challenges in the Monitoring of Multiple Sclerosis Session Chairs: Şeref Demirkaya, Gülşen Akman |
||
| 09:00-09:30 | Clinical and Radiological Biomarkers Serhan Sevim |
||
| 09:30-10:00 | Serological Biomarkers Özgül Ekmekçi |
||
| 10:00-10:30 | Silent Progression Serkan Özakbaş |
||
| 10:30-10:50 | Coffee Break |
||
| 10:50-12:20 | IV. Session: Other Autoimmune Diseases of the CNS Session Chairs: Serkan Özakbaş, Recai Türkoğlu |
||
| 10:50-11:20 | Differential Diagnosis of Optico-Spinal Involvement Uğur Uygunoğlu |
||
| 11:20-11:50 | Serological and Radiological Biomarkers in NMOSD and MOGAD Canan Yücesan |
||
| 11:50-12:20 | Approach to Autoimmune Encephalitis Nur Yüceyar |
||
| 12:20-13:30 | Lunch Break |
||
| 13:30-14:15 | The Place of Ofatumumab in B Cell Therapies - With the contributions of Farmanova Session Chairs: Aksel Siva, Rana Karabudak |
||
| The Place of Ofatumumab in B Cell Therapies and Ofatumumab Clinical Studies Cavit Boz |
|||
| Ofatumumab Real-Life Experiences and Metaanalysis Data Serkan Demir |
|||
| 14:15-14:30 | Coffee Break |
||
| 14:30-16:00 | V. Session: Treatment of Multiple Sclerosis Session Chairs: Aksel Siva, Ömer Faruk Turan |
||
| 14:30-15:00 | Treatment of Benign Multiple Sclerosis Belgin Koçer |
||
| 15:00-15:30 | Treatment of Refractory Multiple Sclerosis Hüsnü Efendi |
||
| 15:30-16:00 | Disease-Modifying Therapies in Multiple Sclerosis: Safety Profile Bilge Piri Çınar, Serkan Demir |
||
| 16:00-16:20 | Coffee Break |
||
| 16:20-17:05 | The Place of Ocrevus in MS Treatment in Light of Current Data - With the contributions of Roche Session Chair: Aslı Tuncer |
||
| Highly Effective DMTs in MS Treatment and Ocrelizumab Uğur Uygunoğlu |
|||
| Ocrelizumab AAN 2024 Data Cihat Uzunköprü |
|||
| 17:05-18:05 | Oral Presentations Session Chairs: Murat Terzi, Nefati Kıylıoğlu |
||
| Speakers: Abdulkadir Tunç, Gökçen Gözübatık Çelik, Melis Suskun |
|||
| 18:05-18:30 | Coffee Break |
||
| 18:30-19:20 | Challenging Cases Oturum Başkanları: Cavit Boz, Aysun Ünal |
||
| Aslı Tuncer Funda Uysal Tan Aylin Akçalı |
|||
| 19:20-19:40 | Coffee Break |
||
| 19:40-19:50 | Rational Drug Use Tahir Kurtuluş Yoldaş |
||
| 20:00-22:00 | Gala Dinner |
||
| 08.30- 09:50 | I. Session: Let's Discuss Together Chairs: Ayşe Sağduyu Kocaman, Yeşim Beckmann |
||
| 08:30-08:50 | B Cell Therapies Can Be Used in Seronegative NMOSD Yes: Mesude Tütüncü, No: Eda Derle Çiftçi |
||
| 08:50-09:10 | Biopsy Should Be Performed in All Possible Cases with Vasculitis Yes: Destan Bünül, No: Cihat Uzunköprü |
||
| 09:10-09:30 | Treatment Can Be Discontinued in MS Patients Yes: Mesrure Köseoğlu, No: Bilgin Öztürk |
||
| 09:30-09:50 | We Should Start to Treat Radiologically Isolated Syndromes Yes: Melih Tütüncü, No: Bedile İrem Tiftikçioğlu |
||
| 10:00-10:30 | Coffee Break |
||
| 10:30-11:30 | II. Session: Key Neuroimmunology Studies in 2023 Session Chairs: Nihal Işık, Nilüfer Kale |
||
| 10:30-11:00 | Basic Science Studies Ahmet Eken, Vuslat Yılmaz |
||
| 11:00-11:30 | Clinical Science Studies Mehmet Fatih Yetkin, Özlem Ethemoğlu |
||
| 11:30-11:45 | Closing Ceremony | ||